Navigation Links
Instituto Gulbenkian de Ciencia scientist wins new Portuguese award Simbiontes for cancer research
Date:12/15/2010

The Simbiontes ("Symbionts" in English) Project brought together children, their families, artists and scientists in a first of its kind fundraising project in Portugal. A true symbiosis was established between several groups in society, leading to this award for scientific research.

Miguel Godinho Ferreira, group leader at the Instituto Gulbenkian de Cincia, just outside Lisbon, is the first scientist to win the 10,000 euros Simbiontes Award, for his proposal to investigate the cellular changes that cause cancer in adults. Over 80% of cancers appear in adults over 50, making age one of the main risk factors for this disease. Miguel Godinho Ferreira's research promises crucial insights into understanding the causes of cancer, and, potentially, into developing approaches to fight the disease.

Miguel's research interests lie in understanding why the incidence of cancer increases with age. He believes he has a clue as to what may underlie this phenomenon: "Chromosome ends have on them protective structures, made up of DNA, called telomeres. As we age, telomeres become shorter, thus acting like molecular clocks that convey the age of a cell."

Telomeres undergo lifelong wear and tear because the enzyme that builds them is not active in human cells. Indeed, telomerase - as this enzyme is called - is active only in the embryo, and becomes inactive at birth. Miguel and his team are looking for the signals associated to telomerase in young cells, that are absent in old cells. They hope to harness these molecular signals to stop cancer developing in older cells. Says Miguel, "If we could manipulate telomerase so that old cells could be tricked into believing they are younger than they really are, it might just be possible to stop cancer from developing. In this project we will try to prove this hypothesis, using first a model organism (yeast), then extending our findings into human cells, and, potentially, paving the way for new therapies.

Miguel Godinho Ferreira's project was chosen amongst 26 proposals that were submitted to an international panel of cancer research experts. The award marks the endpoint of the first edition of the Simbiontes project, put in place by the Associao Viver a Cincia, in collaboration with the Portuguese Institute of Oncology in Lisbon and the arts school Ar.Co. The aim of the project is to raise funds for research, through the engagement of several groups in society. A series of art workshops were run with children at the Institute of Oncology, based on the book "A Menina do Mar" by Sophia de Mello Breyner. The children made several paintings and drawings, that were auctioned in 2009. Furthermore, an illustrated children's book, titled "Os Amigos da Menina do Mar", by Raquel Gaspar (a biologist) and ngelo Encarnao (an artist), was published. The funds raised from the auction of the paintings and drawings, the sales of the book and other activities make up the Simbiontes award.

Miguel adds, "It is an honour to receive the Simbiontes award, for it's spirit as the public's contribution to scientific research. The value of the award is a small contribution to the project, since scientific research is very expensive, but it will allow us to be bolder in our research".


'/>"/>

Contact: Ana Godinho
agodinho@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia
Source:Eurekalert  

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Mensa GLAAM Conference to Feature Christian Drapeau, Stem Cell Author and Scientist
5. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
6. Scientists find donut-shaped structure of enzyme involved in energy metabolism
7. Neuroscientists reveal new links that regulate brain electrical activity
8. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
9. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
10. Scientists Spot Genetic Fingerprints of Individual Cancers
11. AADR awards the 2010 Distinguished Scientist Award to John Greenspan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Instituto Gulbenkian de Ciencia scientist wins new Portuguese award Simbiontes for cancer research
(Date:5/24/2017)... ... May 24, 2017 , ... If you are thinking of a visit to San Francisco ... October is the perfect time to visit. , Business Architecture Associates is pleased to offer ... for individuals, as a 4-½ day package for individuals, and as 4-½ day corporate package ...
(Date:5/24/2017)... ... May 24, 2017 , ... Technique, technique, technique – with a ... lifting weights for strength training and exercise or simply lifting heavy objects, advises Dr. ... position is everything,” Dr. Chang says. “Improper technique in lifting anything heavy or an ...
(Date:5/23/2017)... ... 23, 2017 , ... PM360, the premier information resource for ... winners of its 3rd Annual ELITE Awards. The ELITE (Exceptional • Leaders • ... industry today. , Out of more than 500 submissions, 100 winners were selected ...
(Date:5/23/2017)... ... May 23, 2017 , ... London, May 23, 2017: ... serve earlier this month as a Guest Speaker and Contributor to a weeklong series ... and Common Purpose. , Walter Schindler and SAIL Capital ...
(Date:5/23/2017)... IN (PRWEB) , ... May 23, 2017 , ... ... the availability of video chat as a standard feature on its secure clinical ... from text to voice to video depending on the type and urgency of ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 CSSi, the global leader in ... research industry, is proud to announce the launch of ... website features both enriched content and a customized layout ... the company,s already well-established position as the top global ... "After many months of hard work, we are delighted ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/8/2017)... FLINT, Mich. , May 8, 2017  Diplomat ... WRB Communications, Inc. ("WRB"), a health care ... . WRB specializes in relationship management ... organizations. WRB will ... of Diplomat,s commercialization support services for manufacturers, biotech firms, ...
Breaking Medicine Technology: